Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 5, 1997

View Archived Issues

Fullerene derivative with vasorelaxant effects described by Japanese academics

Licensing agreement signed for OxSODrol

Xenova: half-year 1997 highlights

Antioxidant from Otsuka effective in animal model of nephritis

Generic methylphenidate approved in U.S.

Beneficial effects of TDN-345 in animal models of cerebrovascular disease

Novartis migraine treatment nears U.S. approval

Nicotinic agonist protects against neuronal cell death in rodents

Summary of azelnidipine preclinical data

Russian scientists report on myelopeptides

RPR scientists try a new approach to gpIIb/IIIa antagonists

New antitumor agents from Kyorin and Sagami

SmithKline Beecham synthesizes mechanism-based HSV protease inhibitors

Celgene claims PDE/TNF/NFkappaB inhibitors

Vitamin D derivatives as progesterone antagonists

Warner-Lambert reports novel MMP inhibitors

Antimitotic cryptophycin compounds

Warner-Lambert/CoCensys disclose subtype-selective NMDA antagonists

AWD-140-190: new anticonvulsant with favorable efficacy and safety profile

New 5-HT3 receptor ligand with agonist activity in the gut

Roche seeks European approval for humanized monoclonal antibody

SK-946: a potent and selective muscarinic M1 receptor agonist from Sanwa Kagaku

T-686 inhibits thrombus formation without hemostatic impairment

U.S. patent covering novel CPC-111 formulation

Axcan completes acquisition of U.S. rights to Viokase

RTP licenses improved propofol formulation to AMRAD

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...